会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • SOLUBLE PROTEIN AND UTILIZATION OF THE SAME
    • 可溶性蛋白质及其利用
    • US20120142072A1
    • 2012-06-07
    • US13335282
    • 2011-12-22
    • Hideaki TadaTomoyuki BandoAkio Hayashi
    • Hideaki TadaTomoyuki BandoAkio Hayashi
    • C12N9/16C12N1/19C12N5/10C12N1/21C12N15/55C12N15/63
    • C12Q1/44A61K31/7088C12N9/14C12N9/16G01N2333/916G01N2500/04
    • Disclosed is a method for screening a medicine using a protein, and a compound obtained by the screening method. A compound or a salt thereof inhibiting activity or expression of the protein of the present invention, a neutralizing antibody against the protein, a polynucleotide that are complementary to a polynucleotide coding the protein, and the like can be used as an agent for preventing and/or treating neurodegenerative diseases and the like. Moreover, a compound or a salt thereof enhancing activity or expression of the protein of the present invention, the protein or a partial peptide thereof, a polynucleotide coding the protein, and the like can be used as an agent for preventing and/or treating cancers and the like. Furthermore, the protein of the present invention is useful as a reagent for screening a compound inhibiting or enhancing activity of the protein.
    • 公开了使用蛋白质筛选药物的方法和通过筛选方法得到的化合物。 本发明的蛋白质的抑制活性或表达的化合物或其盐,对蛋白质的中和抗体,与编码该蛋白质的多核苷酸互补的多核苷酸等可以用作预防和/ 或治疗神经变性疾病等。 此外,可以使用增强本发明的蛋白质的蛋白质或其部分肽,编码蛋白质等的多核苷酸的活性或表达的化合物或其盐作为预防和/或治疗癌症的药剂 等等。 此外,本发明的蛋白质可用作筛选抑制或增强蛋白质活性的化合物的试剂。
    • 3. 发明授权
    • Soluble ENPP4 protein
    • 可溶性ENPP4蛋白
    • US08110660B2
    • 2012-02-07
    • US11719730
    • 2005-11-18
    • Hideaki TadaTomoyuki BandoAkio Hayashi
    • Hideaki TadaTomoyuki BandoAkio Hayashi
    • C07K1/00C07K14/00C07K17/00
    • C12Q1/44A61K31/7088C12N9/14C12N9/16G01N2333/916G01N2500/04
    • The present invention relates to a method for screening a medicine using a protein, and a compound obtained by the screening method.A compound or a salt thereof inhibiting activity or expression of the protein of the present invention, a neutralizing antibody against the protein, a polynucleotide that are complementary to a polynucleotide coding the protein, and the like can be used as an agent for preventing and/or treating neurodegenerative diseases and the like. Moreover, a compound or a salt thereof enhancing activity or expression of the protein of the present invention, the protein or a partial peptide thereof, a polynucleotide coding the protein, and the like can be used as an agent for preventing and/or treating cancers and the like. Furthermore, the protein of the present invention is useful as a reagent for screening a compound inhibiting or enhancing activity of the protein.
    • 本发明涉及使用蛋白质筛选药物的方法和通过筛选方法得到的化合物。 本发明的蛋白质的抑制活性或表达的化合物或其盐,对蛋白质的中和抗体,与编码该蛋白质的多核苷酸互补的多核苷酸等可以用作预防和/ 或治疗神经变性疾病等。 此外,可以使用增强本发明的蛋白质的蛋白质或其部分肽,编码蛋白质等的多核苷酸的活性或表达的化合物或其盐作为预防和/或治疗癌症的药剂 等等。 此外,本发明的蛋白质可用作筛选抑制或增强蛋白质活性的化合物的试剂。
    • 4. 发明授权
    • Process for production of radioactive-fluorine-labeled organic compound
    • 放射性氟标记有机化合物的制备方法
    • US08269035B2
    • 2012-09-18
    • US12747726
    • 2008-12-16
    • Fumie KurosakiMasahito ToyamaAkio Hayashi
    • Fumie KurosakiMasahito ToyamaAkio Hayashi
    • C07C69/74
    • C07B59/00C07B59/001C07B2200/05C07C269/06C07C2601/04Y02P20/55C07C271/24
    • A process for production of a radioactive fluorine-labeled organic compound is provided which can improve the yield of radioactive fluorination. Provided is a process in which a compound represented by the following formula (1): (wherein R1 is a straight or branched alkyl chain with 1-10 carbon atoms or an aromatic substituent, R2 is a straight or branched haloalkylsulfonic acid substituent with 1-10 carbon atoms, a straight or branched alkylsulfonic acid substituent with 1-10 carbon atoms, a fluorosulfonic acid substituent or an aromatic sulfonic acid substituent, and R3 is a protective group) is heated under stirring in an inert organic solvent in a presence of a phase transfer catalyst, 18F ions and potassium ions, so as to effect labeling with a radioactive fluorine, wherein the heating temperature is 40-90° C., and the concentration of the phase transfer catalyst in the inert organic solvent is 70 mmol/L or more. Preferably, the molar ratio of the phase transfer catalyst is 0.7 or more relative to the compound of the formula (1), and the concentration of the compound of the formula (1) in the inert organic solvent is 50 mmol/L or more.
    • 提供了可以提高放射性氟化产率的放射性氟标记的有机化合物的制造方法。 本发明提供下述式(1)表示的化合物:其中,R 1为碳原子数为1〜10的直链或支链烷基或芳香族取代基的化合物,R2为直链或支链的卤代烷基磺酸取代基, 10个碳原子,具有1-10个碳原子的直链或支链烷基磺酸取代基,氟磺酸取代基或芳族磺酸取代基,并且R 3是保护基))在搅拌下在惰性有机溶剂中,在 相转移催化剂,18F离子和钾离子,以便用放射性氟进行标记,其中加热温度为40-90℃,相转移催化剂在惰性有机溶剂中的浓度为70mmol / L 或者更多。 相对于式(1)化合物,相转移催化剂的摩尔比优选为0.7以上,惰性有机溶剂中式(1)化合物的浓度为50mmol / L以上。
    • 5. 发明申请
    • METHOD FOR PRODUCTION OF RADIATION DIAGNOSTIC IMAGING AGENT
    • 辐射诊断成像剂的生产方法
    • US20100119448A1
    • 2010-05-13
    • US12526667
    • 2008-02-12
    • Daisaku NakamuraSoichi NakamuraMasahito ToyamaAkio Hayashi
    • Daisaku NakamuraSoichi NakamuraMasahito ToyamaAkio Hayashi
    • A61K51/04
    • C07C229/48A61K9/0019A61K47/26A61K51/0402A61K51/0406C07B59/001C07B63/04C07B2200/05C07C2601/04
    • A method for producing a radioactive diagnostic imaging agent which contains a radioactive halogen-labeled amino acid compound as an effective ingredient and has a composition that can inhibit radiolysis of the effective ingredient, thereby further improving stability, is provided. Disclosed is a method for producing a radioactive diagnostic imaging agent, comprising a solution preparation step of preparing a solution containing a radioactive halogen-labeled amino acid compound, and a dilution step of diluting the solution containing the radioactive fluorine-labeled organic compound in order to adjust radioactive concentration thereof, which further comprises an acid addition step of adding an acid to the solution containing the radioactive fluorine-labeled organic compound, after the solution preparation step and before the dilution step, wherein the acid is added in the acid addition step in an amount sufficient to adjust the pH of the solution resulting from the dilution step to 2.0-5.9, for example, in an amount corresponding to 0.40-2.8 mmol per 1 L of the solution resulting from the dilution step.
    • 提供了含有放射性卤素标记的氨基酸化合物作为有效成分并具有能够抑制有效成分的放射线析出,从而进一步提高稳定性的组成的放射性诊断显像剂的制造方法。 本发明公开了一种放射性诊断显像剂的制造方法,其特征在于,包括:制备含有放射性卤素标记的氨基酸化合物的溶液的溶液制备工序,以及稀释含有放射性氟标记的有机化合物的溶液的稀释步骤, 调整其放射性浓度,其还包括在溶液制备步骤之后和稀释步骤之前在含有放射性氟标记的有机化合物的溶液中加入酸的酸添加步骤,其中在酸添加步骤中加入酸 足以将由稀释步骤得到的溶液的pH调节至2.0-5.9的量,例如,相对于每1L由稀释步骤得到的溶液为0.40-2.8mmol的量。
    • 9. 发明申请
    • Drive operation device of walk-behind lawn mower
    • 行走式割草机驱动作业装置
    • US20070256401A1
    • 2007-11-08
    • US11790208
    • 2007-04-24
    • Yoshihisa HibiGraeme Sidney ParrisAkio Hayashi
    • Yoshihisa HibiGraeme Sidney ParrisAkio Hayashi
    • A01D75/28
    • A01D34/824
    • A walk-behind lawn mower in a form that a handle arm is integrally provided toward an obliquely upper back in a rear of a machine, and a loop handle is provided at a rear end of the relevant handle arm with slightly tilting forward, and a driver performs drive operation while walking following the machine that travels by itself at a back of the machine, includes a throttle lever, the throttle lever being able to be drawn together with the handle by being operated by either of right and left hands grasping the handle, in addition, engine rotation frequency being able to be controlled using the amount of drawing, wherein the throttle lever is rotatably provided on the handle arm in an obliquely lower front or obliquely upper back of the handle.
    • 把手臂一体地设置在机器后部的斜上背部的形式的步行式割草机,并且在稍后向前倾斜的相关把手臂的后端设置有环把手,并且 驾驶员在机器背后的机器行走时执行驾驶操作,包括节流杆,节气门杆能够通过由把手握住的左手和右手中的任一个操作而与手柄一起拉动 此外,能够使用拉伸量来控制发动机转速,其中节流杆可旋转地设置在手柄的手柄的倾斜下前方或斜后方。